Tomotake Shirono

13PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersGene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 25, 2024
Efficacy of Atezolizumab Plus Bevacizumab-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.

Etsuko Moriyama, Shigeo Shimose, Takashi Niizeki

|Sep 28, 2023
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.

Shigeo Shimose, Hideki Iwamoto, Takashi Niizeki

|Oct 14, 2022
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function.

Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu

|Sep 09, 2022
Association between Adverse Events and Prognosis in Patients with Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab: A Multicenter Retrospective Study.

Shigeo Shimose, Hideki Iwamoto, Masatoshi Tanaka

|Jun 03, 2022
Durable complete response is achieved by balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma.

Tomotake Shirono, Hideki Iwamoto, Takashi Niizeki

|May 14, 2022
Hepatitis C Virus Elimination Using Direct Acting Antivirals after the Radical Cure of Hepatocellular Carcinoma Suppresses the Recurrence of the Cancer.

Ryoko Kuromatsu, Tatsuya Ide, Shusuke Okamura

Pageof 3

Frequent Collaborators

12 joint publications

Shigeo Shimose

9 joint publications

Masahito Nakano

8 joint publications

Hironori Koga

7 joint publications

Takumi Kawaguchi